Brooks O'Neil

Stock Analyst at Lake Street

(0.79)
# 3,750
Out of 4,853 analysts
36
Total ratings
25.71%
Success rate
-18.55%
Average return

Stocks Rated by Brooks O'Neil

P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50$20
Current: $6.50
Upside: +207.69%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $30.49
Upside: +41.03%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105$110
Current: $82.55
Upside: +33.25%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $19.45
Upside: +54.24%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40$71
Current: $35.76
Upside: +98.55%
ModivCare
Jan 13, 2025
Maintains: Buy
Price Target: $30$10
Current: $2.31
Upside: +332.90%
AVITA Medical
Jan 8, 2025
Maintains: Buy
Price Target: $20$14
Current: $5.93
Upside: +136.09%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $12.72
Upside: +104.40%
LifeMD
Dec 10, 2024
Initiates: Buy
Price Target: $12
Current: $12.29
Upside: -2.36%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45$55
Current: $29.51
Upside: +86.38%
Maintains: Buy
Price Target: $32$18
Current: $12.28
Upside: +46.58%
Initiates: Buy
Price Target: $5
Current: $2.86
Upside: +74.83%
Maintains: Buy
Price Target: $60$75
Current: $20.18
Upside: +271.66%
Initiates: Buy
Price Target: $12
Current: $6.42
Upside: +86.92%
Maintains: Buy
Price Target: $20$26
Current: $20.15
Upside: +29.03%
Assumes: Buy
Price Target: $45
Current: $5.19
Upside: +767.05%
Initiates: Buy
Price Target: $11
Current: $0.84
Upside: +1,214.53%
Initiates: Buy
Price Target: $128
Current: $27.38
Upside: +365.67%